Karen Pendergrass

Karen Pendergrass, Standards Team

About

Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.

Recent Posts

2026-07-05

Alterations in the gut microbiota of alcoholic cirrhosis patients infected with Clonorchis sinensis in the Pearl River Delta region of China

Among 64 patients with alcoholic cirrhosis in China's Pearl River Delta, those co-infected with the liver fluke Clonorchis sinensis had a distinct gut microbiota. Firmicutes and Prevotella marked the infected group, Enterococcus turned negatively linked to many genera, and the vancomycin-resistance pathway showed the strongest difference (p=0.0088).

2026-07-05

Impact of waterpipe smoking on the salivary microbiome

Among 60 Malaysian men, waterpipe smokers showed a significantly altered salivary microbiome versus non-smokers, with Firmicutes elevated and Proteobacteria depleted, plus 37 shifted metabolic pathways favoring polymer degradation and amino acid metabolism.

2026-07-05

Prevotella histicola

Prevotella histicola is an immunomodulatory human commensal and a leading example of a medicine made from a microbe. It calms autoimmune inflammation, suppressing a multiple sclerosis model as effectively as interferon-beta and showing anti-inflammatory effects in early psoriasis and atopic dermatitis trials as the single-strain therapeutic EDP1815. Unlike its pro-inflammatory relative Prevotella copri, P. histicola is anti-inflammatory.

2026-07-04

Saccharomyces boulardii

Saccharomyces boulardii is a probiotic yeast, a thermotolerant strain of Saccharomyces cerevisiae, used for decades against diarrheal illness. Because it is a eukaryote, antibacterial antibiotics do not kill it, which makes it uniquely suited to preventing antibiotic-associated diarrhea. Its strongest evidence is for antibiotic-associated and traveler's diarrhea, with emerging support for Clostridioides difficile recurrence.

2026-07-04

Saccharomyces

Saccharomyces is a genus of yeasts, best known as brewer's and baker's yeast (Saccharomyces cerevisiae), that appear in the gut mycobiome largely as transient members from fermented foods. The genus is context-dependent: antibodies to it are a classic Crohn's disease marker, its mycobiome balance shifts in liver disease, and one member, Saccharomyces boulardii, is a widely used probiotic.

2026-07-04

Enterococcus

Enterococcus is a genus of hardy Gram-positive gut commensals, led by Enterococcus faecalis and the vancomycin-resistant Enterococcus faecium, that act as major opportunistic hospital pathogens. Enterococcal virulence depends on acquiring the metal manganese, which the host withholds through calprotectin.

2026-07-04

Enterococcus faecium

Enterococcus faecium is a hardy gut commensal that has become a leading hospital pathogen and the E of the ESKAPE group, notorious for vancomycin resistance (VRE). It colonizes the gut and translocates to the bloodstream in vulnerable patients. Its virulence depends on acquiring the metal manganese, which the host withholds through calprotectin.

2026-07-04

Enterobacter

Enterobacter is a genus of Gram-negative Enterobacteriaceae, led by the Enterobacter cloacae complex, that live in the environment and gut and act as ESKAPE hospital pathogens. They carry an intrinsic AmpC beta-lactamase that drives cephalosporin resistance, and as enteric Enterobacteriaceae they share the family's nickel-dependent enzyme systems.

2026-07-04

Actinomycetota

Actinomycetota, formerly called Actinobacteria, is one of the major bacterial phyla of the human gut. It is a broad, high-GC Gram-positive group whose gut role is led by the beneficial Bifidobacterium, especially in infancy, alongside context-dependent members such as Collinsella. As a phylum-level signal it reflects the balance of these very different organisms.

2026-07-04

Hungatella

Hungatella is a genus of anaerobic gut Firmicutes, led by Hungatella hathewayi (formerly Clostridium hathewayi). Though a gut resident, it leans opportunistic: it has been linked to serious human infections and is consistently enriched in colorectal cancer and in sarcopenia, making it a disease-associated rather than beneficial taxon.